How is the Forte Biosciences Inc today?

The Forte Biosciences Inc today is trading in the green, up by 3.32% at 6.53.

How has Forte Biosciences Inc performed historically?

The Forte Biosciences Inc is currently trading up 3.32% on an intraday basis in the past week the index fell -11.04%. The index has been down -49.77% in the past quarter and fell -63.72% in the past year. You can view this in the overview section.

What is Forte Biosciences Inc Annual Net Profit?

Forte Biosciences Inc Annual Net Profit fell 12.71% in the last year to $35.48 M. Its sector's average net profit growth for the last fiscal year was -32.49%.

What is Forte Biosciences Inc Price to Earning Ratio?

Forte Biosciences Inc Price to Earning Ratio is -1.21, which is negative.

What is Forte Biosciences Inc Stock Price?

Forte Biosciences Inc Stock Price fell 63.72% and underperformed its sector by 68.81% in the past year.

What is Forte Biosciences Inc Quarterly Net profit?

Forte Biosciences Inc Quarterly Net profit fell 21.85% YoY to $7.16 M. Its sector's average net profit growth YoY for the quarter was -29.04%.

What is Forte Biosciences Inc Return on Equity(ROE)?

Forte Biosciences Inc Return on Equity(ROE) for the last financial year was -80.82%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Forte Biosciences Inc Mutual Fund Holding?

Forte Biosciences Inc Mutual Fund Holding increased by 1.45% in the last quarter to 22.34.

What is Forte Biosciences Inc Institutional Holding?

Forte Biosciences Inc Institutional Holding remained the same in the last quarter at 66.88%.

Forte Biosciences Inc XNAS: FBRX

Forte Biosciences Inc Live Share Price Today, Share Analysis and Chart

Name: Forte Biosciences Inc: Is Infosys Ltd. worth buying?
Item: Forte Biosciences Inc
Rating: 1.35975
Author: Trendlyne DVM scores

about

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-v...

6.53 0.21 (3.32%)

76.68% Fall from 52W High

2,385 XNAS Volume

XNAS 07 May, 2025 12:26 PM (EDT)

Board Meeting

The next board meeting for Forte Biosciences Inc is on 13 May 2025 for the purpose of Forte Biosciences Inc First Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

12.0 / 100

Technically Neutral

42.4 / 100

No estimates available

Forte Biosciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Forte Biosciences Inc Live Share Price Today, Share Analysis and Chart

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-v...

76.68% Fall from 52W High

SWOT Analysis

Forte Biosciences Inc Live Price Chart

Forte Biosciences Inc FAQ

How is Forte Biosciences Inc today?

Forte Biosciences Inc today is trading in the green, and is up by 3.32% at 6.53.

How has Forte Biosciences Inc performed historically?

Forte Biosciences Inc is currently trading up 3.32% on an intraday basis. In the past week the stock fell -11.04%. stock has been down -49.77% in the past quarter and fell -63.72% in the past year. You can view this in the overview section.